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Understanding Stakeholder Interests and 
Perspectives in Evaluations of Health IT 
Lisa LEE
1 a,
 and Aziz SHEIKH
a
 
a
 Centre for Medical Informatics, Usher Institute of Population Health Sciences and 
Informatics, The University of Edinburgh, Medical School, United Kingdom  
Abstract. Appropriately identifying and representing stakeholders’ interests and 
viewpoints in evaluations of health information technology (health IT) is a critical 
part of ensuring continued progress and innovation in eHealth. This contribution 
therefore seeks to clarify the principles of stakeholder analysis in an eHealth 
context. We describe this with reference to a mixed methods national evaluation of 
ePrescribing systems in English hospitals. We use this evaluation to exemplify the 
engagement and analytical tools required to ensure a detailed understanding of the 
issues, challenges and lessons learnt across stakeholder groups. We conclude that 
this type of approach may support the robustness of evaluations of health IT as 
well as their longer term impact on innovation in the field. 
Keywords. Evaluation, health information technology, stakeholders.  
1. Introduction 
Stakeholder analysis, which includes identifying stakeholders and their interests and 
perspectives, is essential to ensuring a robust health IT evaluation in what are often the 
unpredictable political contexts in which health IT programmes occur. It is not 
uncommon for such programmes to repeatedly encounter delays and resistance before 
any anticipated positive outcomes can be measured [1] making it difficult to produce 
outcome-based evidence. More specifically health IT projects are often upstream 
interventions with relatively diffuse effects, which are difficult to measure [2].  
Yet underlying the questions of measurement, analysis and application of health IT 
evaluations, we find a more fundamental, albeit complex, set of issues in relation to 
how we define stakeholder boundaries of participation, how individual and collective 
views can be brought together systematically and meaningfully to ensure a robust 
evaluation, and how this knowledge can be translated and applied to support optimal 
use of health IT.  
Stakeholders in such evaluations may be broadly defined as those involved directly 
and indirectly in the production and use of health IT at every level. Applying this lens 
allows us therefore to formulate a simplified analytical framework with two major 
groups of actors: producers – seen as those involved in creating the appropriate 
contexts and products for the deployment of health IT (e.g., policy makers, software 
developers); and users, who can be seen as those making direct use of health IT (i.e. 
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end-users), as well as those who derive value or who are expected to benefit from its 
use (e.g. healthcare organisations, patients, and so on).  
The multiple perspectives these stakeholders represent [3] and the degree of 
influence they may exert [4] result in complex stakeholder structures [1]. Added to this, 
the relational quality in terms of the purpose, values, needs and interests of 
stakeholders at key stages in the development, adoption and use of health IT can make 
the position of individual stakeholder groups both complex and fluid. This, in turn, can 
make defining the problems and solutions to system adoptions and use [5] challenging, 
and can risk leading to unsatisfactory recommendations for best practice.  
The crux of the issue in this type of work therefore is ensuring that the evaluation 
of multiple stakeholders involves three steps – collating evidence from different 
stakeholders; analysing and interpreting this information, which by necessity will 
include comparing and contrasting evidence, and responding appropriately to this by 
striking an appropriate balance between maximising benefits of health ITs and 
minimising adverse effects for as many stakeholders as possible.  
To explore this in more detail we have organised the contribution into three core 
areas:  
(1) The principles of stakeholder analysis and the range of stakeholders in health IT 
initiatives, such as purchasers, vendors, professionals, patients, and data 
warehousing and analytics firms.  
(2) Methods of stakeholder analysis, and how tensions may result from the complex 
relationships between actors, divergences in their goals and viewpoints, and how 
these may be addressed in practice.  
(3) Critical walk-through of a national evaluation [6] of hospital ePrescribing systems 
in England. 
2. Principles of stakeholder analysis 
It is now well established that the adoption and use of technology involves multiple 
social processes and unexpected consequences [7-9] on working practices resulting in 
workarounds or ad-hoc local usage policies and practices that shape new technologies 
beyond the point of production or market availability. This complex and multifaceted 
feature of eHealth innovation [4] has led to calls for a more holistic approach [10] to 
the evaluation and deployment of eHealth technologies in order to improve stakeholder 
engagement, participatory design and the interconnectedness of all those involved [11]. 
As such, stakeholder analysis is seen to help support a good ‘fit’ [10] between the 
technology and the environment in which it is used, by facilitating incremental 
improvements to the system over time as use may be optimised [12].  
There are a number of key principles of stakeholder analysis which need to be 
considered at the outset [13] such as: What is the purpose of the analysis? At what 
stage is it occurring? What aspect(s) are being focused on? What resources are 
available to carry out the analysis? What is the timeframe?  
Clearly decisions on these key aspects of the analysis will impact upon the results. 
For instance, an analysis occurring over extended timeframes [8] [14] will ensure that 
stakeholders are accounted for from the point of design right through to primary and 
secondary uses of the technology, yet may be unable to provide the level of detail 
required to understand a specific aspect of the deployment. These parameters need to 
be therefore determined at the point of inception of the evaluation and according to the 
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evidence required. Notwithstanding these dimensions, a stakeholder analysis needs to 
be clear about the actors involved and the perspectives they represent. Thus 
understanding stakeholders’ areas of influence, their expectations and goals, are vital 
since these are seen as determinants in the outcome of health IT adoption [15]. To aid 
in this process, we suggest that a typology of actors, such as the one presented below, 
may provide a useful starting point to explore and map stakeholders and their 
perspectives. 
The simplified schema of stakeholders presented in Figure 1 illustrates a number 
of key points. Firstly, it demonstrates that there may an overlap between areas of 
influence and priority, even within a single stakeholder entity. By way of example, we 
may consider an organisation responsible for the delivery of healthcare nationally, such 
as National Health Service (NHS) England. Within the producer-user schema, the NHS 
may be seen as both the producer of an appropriate context of use (through for instance 
localised policies), as well as being the user of health IT systems, since it is involved in 
the procurement of the technologies it seeks to deploy.  
Such overlaps as well as the distinct goals and expectations of individual 
stakeholders may result in multiple perspectives and agendas being held within or on 
behalf of a single organisation. This is perhaps what typified the introduction of 
Electronic Health Records as part of the National Programme for IT in England, where 
problems emerged from centrally negotiated contracts on behalf on individual hospitals 
[1] and therefore ultimately end-users.  
In practice, this may translate into tensions between stakeholders and divergences 
of expectations with potentially disastrous implications for the engagement of end-
users [8] and the success of the health IT implementation as a whole. In this respect it 
is important to ensure there is a detailed breakdown of individual user groups. For 
instance, even within a single health IT system, there will be divergences and conflicts 
of viewpoints resulting from the functionalities used within the system and individual 
professional tasks, so that the perspectives of each professional group may vary as each 
is may be affected differently by use of the system.  
Addressing these tensions is of course an important aspect of the stakeholder 
analysis. They may be used to both flag up alarm points or areas where additional 
resources and support may be required to ensure successful system adoption, or where 
further evaluation and monitoring may be required to assess whether the tensions and 
conflicts are temporal or likely to be recurring long standing issues. 
Stakeholder perspectives therefore need to be considered within a framework in 
which it becomes possible to disentangle the complex and fluid relationships between 
actors, the changing nature of the relationships and the environments in which health 
IT systems are deployed over time [16] as well as the evolving technologies and 
innovation shifts that occur [17]. In this respect, it is helpful to consider within a health 
IT evaluation how stakeholders’ presence may be mapped and therefore selected over 
the lifecycle [8] of the technology from project initiation right through to deployment 
and beyond (which includes system optimisation and secondary data use).  
In short a stakeholder analysis needs to reflect the ‘social multidimensionality’ 
[18] in which technological appropriation takes place within different institutional 
contexts. It is these changing contexts of use and interests that for many stakeholders 
bring about contradictions between the organisational culture to which they may belong 
and the parameters and resources provided by other stakeholders to which they have to 
conform, even if reluctantly [18].  
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Figure 1. Simplified typology of stakeholders. 
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The implications for those involved in applying stakeholder analyses for the 
evaluation of health IT are clear from a methodological point of view: there is a need 
for flexible, consistent and sufficiently broad ranging evaluation tools that enable these 
multiple, changing and conflicting views to be both evaluated and brought together. 
Below, we consider in more detail how this may be achieved in practice. 
3.  Methods of stakeholder analysis 
Methodologies in the evaluation of health IT systems have come under ever closer 
scrutiny [1, 4, 9-10, 19] and have led to calls to address their shortcomings [19] 
through more holistic models [10] that enable socio-technical factors [12, 20]
2
 and 
multiple perspectives to be concurrently evaluated [5]. While quantitative 
measurements remain a central aspect of health IT evaluations, user-centred bottom-up 
approaches which can usefully be combined with top-down quantitative approaches 
offer the flexibility required to include the divergent perspectives of different 
stakeholders, and ensure a fuller understanding [14] in terms of which individual areas 
may result in positive, negative or neutral outcomes for instance in terms of levels of 
implementation and adoption [21].  
In other words, there is a need for different perspectives to be explored to under-
stand the impact of an intervention, by reflecting how each stakeholder is affected, why, 
and what variables need to be changed or adapted in order to improve outcomes. The 
richness and detail of the qualitative data become especially significant in the era of big 
data, or when anonymous automated reporting is available within a health IT system, as 
they provide the necessary contextual evidence while remaining cost-effective [7]. 
A review of key strategies for the evaluation of eHealth undertaken to date [10] 
clearly shows the multiple axioms along which health IT evaluations have been 
designed to capture a wide variety of stakeholder perspectives and views. As suggested 
earlier on in this contribution, a number of considerations need to be made both at 
theoretical and empirical levels to align the design of the evaluation with its intended 
outcomes, as this will support the robustness of the stakeholder analysis.  
The evaluation of health IT by means of stakeholder analysis will need to consider 
first the perspectives that are being captured and analyzed, including whether the 
analysis is user-centered, multi-faceted and/or multidisciplinary. Weight will also need 
to be given to contextual factors and frameworks, including legislative, commercial, 
economic, or socio-technical. The timescales of the evaluation will also be a 
determinant of the outcome of the stakeholder analysis as views, perspectives and 
interests may change over time. Therefore whether the analysis is continuous, iterative 
or phased, will constitute an additional methodological consideration. Finally, special 
attention needs to be given to ensuring on which aspects of a health IT deployment or 
adoption are stakeholders’ perspectives being sought and what benchmarks are being 
used to define their perspectives, including whether stakeholders views and interests 
relate to structure, process, outcomes, procedures, performance or a combination of 
these.  
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With all this in mind, it will become easier to define the appropriate 
methodological evaluation approaches, such as quantitative clinical trials, qualitative 
case studies or in larger studies, mixed methods that are able to offer a combination of 
approaches.  
4. Example: Evaluation of ePrescribing in England 
The UK’s National Institute for Health Research (NIHR) funded evaluation of 
ePrescribing in England [6] provides a good illustration of the principles and 
methodological considerations of stakeholder analysis discussed so far, including (1) 
appropriate mapping of stakeholders and their changing interests and viewpoints over 
time, and (2) methodological approaches that ensure the ability to capture and 
triangulate stakeholder perspectives, and to engage with the stakeholder-base as part of 
the research process. Below we provide a critical walk through how each of these areas 
has been addressed in this national evaluation of ePrescribing. 
 
4.1. ePrescribing stakeholders 
The national ePrescribing evaluation highlights not only the multiple actors involved in 
large scale health IT deployments but also how their expectations and interests can be 
brought together in an attempt to find resolutions to any conflicts and divergences.  
The stakeholder-base involved in the implementation and adoption of ePrescribing 
systems that offer varying degrees of functionality in the supply, administration, 
recording and ePrescribing of medication [22] is wide-ranging and includes both 
producers and users of technology, as discussed earlier. The evaluation has therefore 
sought to capture the perspectives of: physicians, nurses, pharmacists, and other 
healthcare professionals; health IT suppliers; patients and carers; policy-makers; 
hospital managers, IT and finance teams. It has done so by collecting qualitative 
interview data from key stakeholders, including end-users in case study hospitals 
before as well as three to six months post-implementation, and again once the system 
might be considered embedded. This has enabled a longer-term perspective on the 
introduction and use of ePrescribing systems in English hospitals to be taken in order to 
take into account evolving situations and to assess how changes that happen over time 
may impact on stakeholder perspectives [8].  
Many eHealth implementations are tainted, especially in immature digital markets 
[12] with unrealistic and wide-ranging expectations that have adverse effects on 
engagement [12,14,23-26] which may provide falsely negative stakeholder perspectives 
for instance if the system is considered having few benefits, when problems may in fact 
be the result of lack of readiness.  
The collation of detailed case studies of hospitals deploying ePrescribing systems 
with different functionalities, at different stages of deployment and adoption, and in 
different geographical regions, has allowed therefore for cross-comparisons and 
disconfirming searches to help understand divergences and similarities between sites. 
This strategic selection of case studies has provided an opportunity to balance 
stakeholder perspectives and conflicting views when developing recommendations for 
best practice. This type of approach further allows the narrative behind the introduction 
and adoption of ePrescribing to be meaningfully applied throughout the lifecycle of the 
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system [8] and to establish when behaviour, events or technical issues are transient, and 
where results suggest a longer term effect. This longer-term perspective is seen as 
especially critical in the context of an immature product, such as ePrescribing, which 
will be shaped by its users and the context within which it is being used.
3
  
4.2. Mixed methods for robustness of stakeholder analysis 
While the ability to capture and contrast stakeholder perspectives over time was in the 
ePrescribing evaluation achieved by means of qualitative case studies, robustness of the 
stakeholder analysis has been enhanced through the use of mixed methods 
4
 which 
provide complementary stakeholder perspectives at key stages [27] along the system 
development and care pathways (supplier, NHS organisation, patients).  
This mixed method approach has provided measurements in various forms of the 
anticipated benefits of ePrescribing, by looking both qualitatively and quantitatively at 
safety and error rates [28], efficiency and cost benefit [2] and communication [12, 25, 
29].  
It is important to note also how the perspectives of patients – a key yet often 
neglected stakeholder group – has been facilitated through the inclusion of a Patient 
and Public Involvement Group throughout the evaluation to influence and challenge 
perspectives individually and collectively at each stage of the research. Importantly, 
these research strategies and tools, as well as the findings being generated from them, 
have been used to engage and inform stakeholders via an online toolkit 
www.ePrescribingtoolkit.com [30]. This provides not only engagement but also an 
alignment of the goals of stakeholders by supporting and promoting successful 
implementation strategies that draw on evidence-based research.  
Findings from the stakeholder analysis can thereby remain both reflective and 
outwardly engaging towards ePrescribing stakeholder communities, whether they be 
commercial players, policy-makers, health organisations or clinicians as well as 
patients themselves, and may help unpick the complex relationships between 
stakeholders [13] at critical stages in the health IT systems’ adoption [27]. The toolkit 
alongside various closed and open stakeholder events organised as part of the 
evaluation [31] have moved the analysis beyond identifying its stakeholder-base and a 
description of their perspectives, to an active form of participation in the research as 
stakeholders are both subjects and users of the research, thus allowing knowledge 
derived from the analysis to be applied meaningfully.  
5. Conclusions 
It is worth remembering that while we advocate the use of a stakeholder analysis that 
enables as many perspectives as possible to be considered over extended timeframes 
and at different stages of health IT deployments, practical considerations such as costs, 
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resources, expertise and so on, do need to be taken into account and compromises will 
need to be made where necessary.  
In the context of the ePrescribing evaluation, this included the strategic selection of 
case study sites which hold particular known characteristics to enable a good balance 
between reliability and efficiency of data collection, attaching local researchers to 
individual sites as well as collaborative modalities of data collection at each site, for 
instance when ward pharmacists collected quantitative data on error rates as part of 
daily ward rounds. 
While the complexity of the stakeholder relationships and the reconciliation of 
their perspectives to help foster technological usability, innovation and participation 
may be addressed through integrated methodological approaches [19, 32-33] and 
transdisciplinary collaboration [5,9] stakeholder analyses are far from straightforward 
[19]. A number of steps may help address the difficulties encountered.  
Firstly, ensuring the timing of the analysis is appropriate enables the evolving 
nature of health IT [12] and its diffuse effects [2] to be considered. Secondly, when 
wide ranging issues from usability and design, staff training, increased time required to 
perform clinical duties, or the impact of eHealth systems on face-to-face interactions 
between patients and Health Care Professionals are flagged up during the analysis, it is 
vital to support appropriate utilisation of this knowledge [34] to address the 
translational gap in its application [35]. A stakeholder analysis which is being used as 
part of a health IT evaluation needs to consider fully therefore how best to manage 
findings [36] to allow stakeholders appropriately to plan, implement and make optimal 
use of this knowledge when expertise of eHealth system implementations and adoption 
is limited [30, 37]. This will help address challenges posed by conflicting stakeholder 
perspectives, such as when interventions are viewed positively by patients, but are 
found to be ineffective or not cost-effective in the analysis. Finally, it is worth noting 
that variations globally in how healthcare technologies may be adopted are significant 
for the applicability of a stakeholder analysis. Indeed local norms may affect the 
usefulness of a stakeholder analysis [13]. As such it is important to be mindful both of 
the feasibility and usefulness of seeking multiple stakeholder perspectives in particular 
geographical settings globally with distinct organisational cultures.  
The points we have made throughout this contribution should be a stark reminder 
to both policy makers and researchers in the field that health IT evaluations do need 
appropriate time, methodological approaches, resources and expertise if they are to 
fulfil their objective.  
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Food for thought 
1. What are the key ways in which the complex stakeholders’ perspectives can be 
evaluated? 
2. How can knowledge transfer be used to help balance stakeholder perspectives in 
the evaluation? 
3. What issues might arise in the evaluation of health IT systems across 
organisational cultures or geographical settings? 
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